CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - EUR (€) € in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revenue
Research and development services	€ 0	€ 104
Grants	297	279
Total revenue	297	383
Expenses
Research and development	308	667
General and administrative	277	330
Depreciation	8	9
Directors' fees	5	5
Foreign exchange and other	(65)	(35)
Total expenses	533	976
Operating loss	(236)	(593)
Interest expense	653	646
Loss before income tax (provision) benefit	(889)	(1,239)
Income tax (provision) benefit	(9)	0
Net loss	(898)	(1,239)
Other comprehensive income (loss)
Foreign currency translation adjustment	(1)	2
Comprehensive loss	€ (899)	€ (1,237)
Basic and diluted earnings per share	€ (0.00)	€ (0.00)